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Abstract
Background: With renewed interest in malaria elimination, island environments present unique opportunities to 
achieve this goal. However, as transmission decreases, monitoring and evaluation programmes need increasingly 
sensitive tools to assess Plasmodium falciparum and Plasmodium vivax exposure. In 2009, to assess the role of 
serological markers in evaluating malaria transmission, a cross-sectional seroprevalence study was carried out in Tanna 
and Aneityum, two of the southernmost islands of the Vanuatu archipelago, areas where malaria transmission has been 
variably reduced over the past few decades.
Methods: Malaria transmission was assessed using serological markers for exposure to P. falciparum and P. vivax. Filter 
blood spot papers were collected from 1,249 people from Tanna, and 517 people from Aneityum to assess the 
prevalence of antibodies to two P. falciparum antigens (MSP-119 and AMA-1) and two P. vivax antigens (MSP-119 and 
AMA-1). Age-specific prevalence was modelled using a simple catalytic conversion model based on maximum 
likelihood to generate a community seroconversion rate (SCR).
Results: Overall seropositivity in Tanna was 9.4%, 12.4% and 16.6% to P. falciparum MSP-119, AMA-1 and Schizont 
Extract respectively and 12.6% and 15.0% to P. vivax MSP-119 and AMA-1 respectively. Serological results distinguished 
between areas of differential dominance of either P. vivax or P. falciparum and analysis of age-stratified results showed a 
step in seroprevalence occurring approximately 30 years ago on both islands, indicative of a change in transmission 
intensity at this time. Results from Aneityum suggest that several children may have been exposed to malaria since the 
2002 P. vivax epidemic.
Conclusion: Seroepidemiology can provide key information on malaria transmission for control programmes, when 
parasite rates are low. As Vanuatu moves closer to malaria elimination, monitoring changes in transmission intensity 
and identification of residual malaria foci is paramount in order to concentrate intervention efforts.
Background
Malaria elimination is once again a stated goal for a num-
ber of malaria-endemic countries [1]. In areas where
transmission intensity is low, malaria control pro-
grammes are considering switching from sustained con-
trol to elimination. Monitoring of malaria transmission
intensity (MTI), and targeting interventions to settle-
ments experiencing higher malaria transmission will be
vital in this endeavour [2]. Interventions in geographi-
cally isolated areas, such as islands, may be more success-
ful due to better control of imported transmission,
geographically defined areas to target, and high commu-
nity participation [3,4]. Sustained control efforts and
monitoring in these areas can lead to the successful erad-
ication of malaria, such as occurred in Mauritius in the
1960s [5].
However, areas of low transmission, or areas where
transmission has been reduced substantially, pose consid-
erable challenges for monitoring and evaluation. Expo-
sure to infection can be markedly heterogeneous which
can be an important determinant of the rate of progress,
and thus the time required to achieve elimination [6].
When transmission is low, traditional measures of MTI
such as the entomological inoculation rate (EIR) and par-
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asite rates (PR) lack sensitivity because numbers of posi-
tive samples (mosquito and human) are low. Additionally,
the low frequency of positive samples represents a formi-
dable logistical challenge, and further, both entomologi-
cal and parasitological measures are affected by
seasonality [7-9]. An alternative measure for MTI is to
calculate the prevalence of anti-malaria antibodies in the
local population. Serological markers of transmission
show greater sensitivity in low transmission areas, as
seroprevalence reflects cumulative exposure and thus is
less affected by seasonality due to the longer duration of
specific antibody responses. Sample collection and analy-
sis can be readily scaled up, and analysis is relatively sim-
ple, making this approach adaptable for resource poor
settings [10].
Seroepidemiological studies have previously been used
to assess malaria transmission intensity [11], reductions
in transmission [12-14] and malaria eradication [5,15,16].
However, variation in source of antigen and the subjectiv-
ity of the detection methods led to this method falling out
of favour [17]. The availability of specific recombinant
malarial antigens, and the development of standardized,
sensitive enzyme-linked immunosorbent assays (ELISA)
mean that seroepidemiological study has once again
become an attractive methodology, both for assessment
of malaria transmission and for assessing changes in
prevalence following the implementation of control pro-
grammes [10,18-21].
The utility of serological markers as a methodology for
describing malaria exposure was investigated as part of
the evaluation of malaria elimination efforts in Vanuatu.
Vanuatu is a South Pacific archipelago made up of over 80
islands, each with varying levels of malaria transmission.
There have been several large-scale control programmes
implemented in the country over the last 50 years and a
reduction in reported cases has been recorded over the
last decade (Ministry of Health, Vanuatu). In March 2008,
the Vanuatu government revised the goal of their
National Malaria Programme (NMP) from control to
elimination, with the aim to eliminate malaria from Tafea,
the most southerly province, by 2015 (Figure 1). The most
southerly island of the province, Aneityum (Population
c.800), has been subject to extensive malaria control pro-
grammes. There were no reported malaria cases on Ane-
ityum between 1991 and 2002, when a P. vivax epidemic
occurred [3]. Since 2002, no more cases have been
reported. Tanna, the second largest of the islands in the
province, (Population c.20,000) is characterized by low
but continuing P. falciparum and P. vivax transmission. A
malariometric study performed in 2008 revealed low level
parasitaemia and mainly coastal transmission for both
species [22].
This paper reports on the sero-epidemiological results
from samples collected from Tanna and Aneityum in May
2009, with the aim of assessing the utility of specific sero-
logical tools for both ongoing monitoring of MTI, and
assessment of changes in MTI, in the pre- and post-elimi-
nation era.
Methods
Study site and population
Tanna and Aneityum are in Tafea Province, in southern
Vanuatu (Figure 1). The main occupation in the province
tends to be subsistence farming which takes place year
round. Group meetings take place in Nakamals (central
meeting place), and men often convene (often in the eve-
nings) to drink kava (a sedating drink) in these areas.
Knowledge of malaria is predominantly high, although
community adherence to protective measures can be low
where the threat is perceived as minimal[23]. Rainfall is
seasonal, with a wet season from January to May. The
only known malaria vector is Anopheles farauti [3]. In
1988, country-wide distribution of insecticide-treated
nets (ITNs) began, following the cessation of indoor
residual spraying (IRS)[24].
Tanna
Tanna has a population of approximately 20,000 (1999
census). Both P. falciparum and P. vivax malaria occur on
Tanna. In 2008, a prevalence study using species specific
PCR of samples obtained from school children identified
three main areas of malaria transmission [22] (Figure 2).
Briefly, Northern Tanna (Hebron/Lounapil) had the high-
est malaria prevalence with 2.1% (10/486) and 4.7% (23/
486) positive for P. falciparum and P. vivax respectively;
the Northern highlands had the lowest with 2.5% (12/
481) and 1.9% (9/481) for P. falciparum and  P. vivax
respectively; and the Southern Coast of Tanna (Etakua/
Kwamera) had very low levels of P. falciparum (0.5%, 3/
576) but higher levels of P. vivax (5.0%, 29/576). These
figures are summarized in Figure 2. Communities living
in these settlements were asked to participate in the
seroepidemiological study.
Aneityum
Aneityum lies to the south of Tanna and is much smaller.
The island is sparsely inhabited with a population of
approximately 800 distributed in three main settlements.
Due to weather constraints during the survey, samples
were only collected from two of the three settlements;
Anel and Port Patrick. Results for these two settlements
have been combined for the majority of the analyses. In
Aneityum, weekly mass drug administration (using Pri-
maquine with chloroquine and pyrimethamine with sul-
phadoxine) was carried out for 9 weeks in 1991.
Larvivorous fish were simultaneously introduced into
identified breeding sites of An. farauti [3]. No parasites
h a v e  b e e n  d e t e c t e d  b y  m i c r o s c o p y  i n  a n n u a l  s u r v e y s
since 2003 (A. Kaneko; personal communication).Cook et al. Malaria Journal 2010, 9:169
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Figure 1 Location of Tanna and Aneityum, Vanuatu in the South West Pacific. Map of Vanuatu showing the location of Tafea Province within 
the country and the location of Vanuatu with respect to neighbouring countries in the Western Pacific region (inset).Cook et al. Malaria Journal 2010, 9:169
http://www.malariajournal.com/content/9/1/169
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Figure 2 Summary of Plasmodium speciation PCR results obtained from Tanna in 2008. PCR results for children over 2 and under 15 are pre-
sented, adapted from data presented in Reid et al [22]. Each black spot represents the home settlement of at least one child involved in the survey. 
Children were sampled from a total of 44 villages across three settlements on Tanna.Cook et al. Malaria Journal 2010, 9:169
http://www.malariajournal.com/content/9/1/169
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Survey methodology
The cross-sectional survey took place in May 2009. Par-
ticipants were recruited to the study by the Ni-Vanuatu
malaria control team. Village leaders were sensitized to
the study by trained field workers and together provided
information to community members at community meet-
ings. Community members willing to participate were
asked to complete a written Informed Consent Form by
providing a signature or witnessed thumbprint. A central
meeting point was chosen (nakamal, or a school or com-
munity centre) and families were invited from surround-
ing villages to be part of the survey. A cross-section of the
population was sampled, with high levels of community
participation. Demographic data were collected for each
person, including age, sex and details on whether they
owned a bed net, and had used a bed net the previous
night. Participants were tested with a rapid diagnostic
test (ICT COMBO cassette) if they presented with a fever
and were treated accordingly if the test was positive. Fin-
ger prick blood samples were collected on labelled What-
man 3 mm filter paper, allowed to air dry and then
p a c k a g e d  i n  s e a l a b l e  b a g s  c o n t a i n i n g  s i l i c a  g e l ,  b e f o r e
being transported for analysis in Brisbane, Australia.
Assay of anti-malarial antibodies
A n t i b o d i e s  w e r e  e l u t e d  f r o m  f i l t e r  p a p e r  b l o o d  s p o t s
(FPBS) and assayed by ELISA as previously described
[19]. Briefly, a 3.5 mm circle was cut from the spot and
placed into 300 μl of phosphate buffered saline with 0.5%
tween20 (PBS-T) and 0.05% sodium azide, approximately
equivalent to a 1/200 serum dilution. All samples were
tested for the presence of human antibodies (IgG) against
merozoite surface protein-119 (MSP-119) and apical mem-
brane antigen-1 (AMA-1) of P. falciparum (MSP-119-
Wellcome strain, AMA-1-3D7) and P. vivax (MSP-119-
Belem strain, AMA-1 (Sal-1). Samples were also tested on
freeze thawed P. falciparum Schizont Extract (concentra-
tion of 1 × 108/ml) which was coated onto plates at 1/500.
Briefly, each antigen was coated on high absorbance
plates (Immunlon4) at 0.5 μg/ml and stored at 4°C over-
night. The plate was washed three times in PBS-T and
blocked for 3 hours with 1% (w/v) milk powder. Following
three more washes, samples were added in duplicate at a
final dilution of 1/1000. A pool of sera from a highly
endemic area in Africa was titrated on each plate as a
positive control. The following day, following five washes,
anti-human IgG HRP (DAKO) was incubated in each
plate for three hours. The plates were then developed
using OPD (Sigmafast) for 20 minutes in the dark. Plates
were read at 492 nm on a Molecular Devices Versa Max
ELISA reader.
Statistical methods
The serology survey data was double entered into sepa-
rate Microsoft Excel spreadsheets. The completed
spreadsheets were converted to Microsoft Access data-
bases which were compared using the FLG comparison
script [25] which yielded 1.67% differences in entry that
were corrected and checked again. The resulting double
entered database was logically validated for value homo-
geneity and range checking, using scripts developed in
SAS/STAT software (v1.93 for Windows). The cleaned
database was then converted back to Microsoft Excel for
analysis in STATA (v.10).
Samples where duplicate optical densities (ODs) had
more than 20% variation between them were excluded
from the analysis. Raw ODs were transformed into titres
using the standard curve to normalize between plates and
dichotomized into positive or negative using a mixture
model, as described previously [19]. Similar models have
been used for defining cut offs for the Mantoux test for
tuberculosis where pre-exposure to environmental bacte-
ria can cause non-specific reactions [26] and also in sero-
logical tests for measles and rubella [27,28]. Briefly, the
data were fitted using maximum likelihood methods to
establish seronegative and seropositive Gaussian distri-
butions. For each antigen, the cut off was then set as the
mean titre of the seronegative distribution plus three
standard deviations [20].
A simple reversible catalytic model was fitted to the
dichotomized data using maximum likelihood methods
[18]. The model generates a seroconversion rate (SCR or
λ) and a seroreversion rate (ρ). For the purposes of this
study the seroreversion rate was not fixed and allowed to
vary as determined by the model. The model was used to
generate age seroprevalence curves, from which a sero-
conversion rate (SCR) representing the force of infection
for the community was calculated. If visual examination
of SCR suggested it was not uniform over the whole pop-
ulation (i.e. there was an obvious step in the age seroprev-
alence data), models allowing for two forces of infection
profile and profile likelihood plots were run to determine
when the most likely time for change in transmission
intensity occurred (or at what age the step in seropreva-
lence occurs) [20]. These resulted in a predicted time of
change in transmission (and 95% confidence intervals),
which was subsequently incorporated into the catalytic
model to generate estimates for previous and current
SCR. Models allowing for two forces of infection were
preferred if the fit compared to the single force model
was significantly better by likelihood ratio (LR) test at a p
< 0.05.
The PfSE antigen is multi-antigenic and not necessarily
specific for P. falciparum antigens as many of the same
proteins are likely to be present in other species of Plas-
modium and possibly in other infections. Therefore, the
analysis primarily focuses on the results for the specific
antigens analysed. Village of residence was mapped based
on coordinates recorded the previous year [22]. Mean
seroprevalence in children (to represent recent and localCook et al. Malaria Journal 2010, 9:169
http://www.malariajournal.com/content/9/1/169
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transmission) aged between 1 and 10 (inclusive) was plot-
ted by village using ArcGIS (v.9.3.1). Logistic regression
was used to compare differences in seroprevalence
between settlements, whilst controlling for age group.
Ethical approval
This research was approved by the Vanuatu Ethics Com-
mittee, Ministry of Health, Vanuatu and by the University
of Queensland.
Results
A total of 364, 515 and 370 people were recruited from
North Tanna, the Northern Tanna Highlands and South-
ern Tanna respectively. Five hundred and seventeen peo-
ple were recruited from Aneityum from two of the three
villages. Fewer men were sampled than women (854/906)
but this difference was not significant, and the ratio did
not vary across clusters (Chi2 p = 0.87). Sampling often
took place in schools, meaning that children of school age
were more heavily sampled- the age distribution varied
slightly depending on the cluster (Table 1). In total, 65%
of people sampled were under the age of 20, a figure that
is higher than the 55% national distribution [29].
Due to current malaria control activities, ownership
and reported use of bed nets was generally high, with
usage close to 80% in Northern Tanna, Southern Tanna
and Aneityum (Table 1). However in the Northern high-
lands in Tanna the reported usage of nets was lower, with
only 38% (167/436) of survey respondents reporting to
have used the nets the night before despite 98% (503/512)
reporting they owned nets (Table 1). This is likely to be a
result of the perceived low malaria risk in this area[23].
Antibody responses in the population
Seroprevalence for each settlement, by age group, is sum-
marized in Table 2 and Figure 3. Overall, seroprevalence
increased with age and was higher to AMA-1 antigens
than to MSP-119 antigens. Seroprevalence was highest to
PfSE. There was no difference in seroprevalence between
males and females for any of the antigens tested (p > 0.1
for all antigens). Overall, seropositivity in Tanna was 9.4%
and 12.4% and 16.6% for P. falciparum MSP-119, AMA-1
and PfSE respectively and 12.6% and 15.0% for P. vivax
MSP-119 and AMA-1 respectively. In Aneityum, seroposi-
tivity was 6.6%, 5.8% and 11.8% for P. falciparum MSP-
119, AMA-1 and PfSE respectively and 6.2% and 10.1% for
P. vivax MSP-119 and AMA-1 respectively.
The seroprevalence data suggest that residents in
Northern Tanna have experienced the highest exposure
to P. falciparum malaria infection, with 22% (79/358) of
individuals being seropositive to one or both of the spe-
cific P. falciparum antigens tested. Southern Tanna had
the lowest specific P. falciparum seroprevalence (5%, 20/
369). P. vivax seroprevalence was also highest in North-
ern Tanna (30%, 107/361), followed by Southern Tanna
(25%, 92/369), with the lowest seroprevalence in the
Northern Tanna Highlands (11%, 54/512).
Figure 3 demonstrates the increasing seroprevalence
from PfMSP-119 to PfAMA with the highest seropreva-
lence to PfSE in each settlement. Interestingly, children
Table 1: Population demographics of survey participants (%(n))
Northern
Tanna
(n = 364)
Northern Tanna
Highlands
(n = 515)
Southern 
Tanna
(n = 370)
Aneityum
(n = 517)
Total
(n = 1766)
Male 47.3 (172) 48.1 (245) 50.3 (186) 48.6 (251) 48.5 (854)
Sex Female 52.8 (192) 51.9 (264) 49.7 (184) 51.5 (266) 51.5 (906)
Not recorded 060 0 6
0-5 18.4 (67) 23.1 (119) 14.1 (52) 17.4 (90) 18.6 (328)
5-20 48.4 (176) 42.9 (221) 52.7 (195) 42.4 (219) 45.9 (811)
Age (Years) 20-80 33.2 (121) 34.0 (175) 33.2 (123) 40.2 (208) 35.5 (627)
Total 100 (364) 100 (515) 100 (370) 100 (517) 100 (1766)
No 21.8 (79) 61.7 (269) 11.1 (41) 10.1 (52) 26.1 (441)
Used a bed net the 
night before the 
survey
Yes 78.2 (284) 38.3 (167) 88.9 (329) 89.9 (465) 73.8(1245)
Not recorded 17 90 0 8 0C
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Table 2: Seroprevalence to four malarial antigens by age group
Location Age 
group 
(years)
N Pf 
MSP
Pf MSP 
+ve
% Pf MSP +ve N Pf 
AMA
Pf AMA 
+ve
% Pf AMA 
+ve
N Pf SE Pf SE 
+ve
% PfSE +ve N Pv 
MSP
Pv MSP 
+ve
% Pv MSP +ve N Pv AMA Pv AMA 
+ve
% Pv AMA+ve
0-5 64 4 6.3 (1.6-12.3) 65 7 10.8 (3.0-18.5) 66 5 7.6 (1.0-14.1) 66 13 19.7 (9.8-29.5) 65 8 12.3 (4.1-20.5)
Northern 
Tanna
5-20 176 15 8.5 (4.4-12.7) 174 29 16.7 (11.1-22.3) 176 25 14.2 (9.0-19.4) 172 27 15.7 (10.2-21.2) 175 20 11.4 (6.7-16.2)
20-80 121 44 36.4 (27.7-45.1) 119 43 36.1 (27.4-45.0) 120 68 56.7 (47.7-65.7) 119 37 31.1 (22.7-39.5) 121 41 33.9 (25.3-42.4)
Total 361 63 17.5 (13.5-21.4) 358 79 22.1 (17.8-26.4) 362 98 27.1 (22.5-31.7) 357 77 21.6 (17.3-25.9) 361 69 19.1 (15.0-23.2)
0-5 115 3 2.6 (0-5.6) 119 5 4.2 (0.5-7.9) 119 1 0.8 (0.0-2.5) 117 6 5.1 (1.1-9.2) 119 4 3.4 (0.1-6.6)
Northern 
Tanna 
Highlands
5-20 216 13 6.0 (2.8-9.2) 218 14 6.4 (3.1-9.7) 221 12 5.4 (2.4-8.4) 216 14 6.5 (3.2-9.8) 220 15 6.8 (3.5-10.2)
20-80 173 21 11.6 (7.2-17.1) 174 35 20.1 (14.1-26.1) 176 66 37.9 (30.6-45.2) 174 12 6.9 (3.1-10.7) 173 22 12.7 (7.7-17.7)
Total 504 37 7.3 (5.1-9.6) 511 54 10.6 (7.9-13.2) 514 79 15.4 (12.2-18.5) 507 32 6.3 (4.2-8.4) 512 41 8.0 (5.6-10.4)
0-5 52 1 1.9 (0-5.8) 52 2 3.8 (0-9.3) 51 0 0.0 51 5 9.8 (1.4-18.3) 52 8 15.4 (5.2-25.5)
Southern 
Tanna
5-20 195 3 1.5 (0-3.3) 188 7 3.6 (1.0-6.2) 192 3 1.6 (0.0-3.3) 195 22 11.3 (6.8-15.8) 194 31 16.0 (10.8-21.2)
20-80 123 12 9.8 (4.4-15.1) 122 11 9.0 (3.9-14.2) 121 26 21.5 (14.1-28.9) 123 19 15.5 (9.0-21.9) 122 37 30.3 (22.1-38.6)
Total 370 16 4.3 (2.2-6.4) 349 20 5.4 (3.1-7.7) 364 29 8.0 (5.2-10.8) 369 46 12.5 (9.1-15.9) 368 76 20.7 (16.5-24.8)
0-5 90 1 1.1 (0-3.3) 90 4 4.4 (0.1-8.8) 90 4 4.4 (0.1-8.7) 90 3 3.3 (0-7.1) 88 3 3.4 (0-7.3)
Aneityum 5-20 218 9 4.1 (1.5-6.8) 218 10 4.6 (1.8-7.4) 219 5 2.3 (0.3-4.3) 219 9 4.1 (1.5-6.8) 210 12 5.7 (2.6-8.9)
20-80 208 24 11.5 (7.2-15.9) 208 16 7.7 (4.0-11.1) 208 52 25 (19.1-30.9) 208 20 9.6 (5.6-13.7) 207 36 17.4 (12.2-22.6)
Total 516 34 6.6 (4.4-8.7) 516 30 5.8 (3.8-7.8) 517 61 11.8 (9.0-14.6) 517 32 6.2 (4.1-8.3) 505 51 10.1 (7.5-12.7)
Number of positive individuals and seroprevalence (95% CIs) to PfMSP-119, PfAMA, PfSE, PvMSP-119 and PvAMA for three age groups in three settlements on Tanna and two settlements combined on AneityumCook et al. Malaria Journal 2010, 9:169
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under five consistently had lower seroprevalence to PfSE
than to the specific antigens. This contrasts with adults
who had the highest seroprevalence to PfSE in all settle-
ments.
Seroprevalence to specific antigens in children between
the ages of 1 and 10 years (inclusive) by village is shown in
Figure 4. It suggests that exposure is not uniform across
the settlements with focal areas becoming evident in
Figure 3 Seroprevalence to P.falciparum and P.vivax antigens in 3 settlements from Tanna and from two settlements combined on Ane-
ityum, by three age groups
 
A) 
B) Cook et al. Malaria Journal 2010, 9:169
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North Tanna and Southern Tanna. Unfortunately num-
bers were too small to allow for micro-spatial analysis.
Changes in transmission intensity over time
Changes in transmission intensity were identified most
readily for PfSE, with weak evidence in responses to the
more specific PfMSP-119 seroprevalence (Figure 5). No
clear peaks were identified for PfAMA or for the two P.
vivax antigens. For PfMSP-119, the PLPs did not show
strong evidence for a change in transmission, as demon-
strated by the log likelihoods all being above the 95% con-
fidence intervals (Figure 5) however, the MSP-119 PLPs
generally peaked at the same point as the PfSE plots. The
maximum log likelihoods indicate that a reduction in P.
falciparum  transmission intensity occurred approxi-
m a t e l y 3 0 y ea rs  a g o in Nort he rn  T a nna  ( P f S E PLP:  33
years (95% CI: 27-50) and the North Tanna Highlands
(PfSE PLP: 28 years (22-32 years)), 23 years ago in Ane-
ityum (PfSE PLP: 23 years (21-32 years)) and approxi-
mately 18 years ago in Southern Tanna (PfSE PLP: 18
years (9-28 years)). The resulting SCRs suggest a 3, 9 and
12 fold decrease in transmission for North Tanna, North
Tanna Highlands and Southern Tanna respectively (Fig-
ure 6). Transmission on Aneityum appears to have
decreased over seven-fold. Although the decrease in
transmission is not reflected in the age seroprevalence
data for the specific antigens, the SCRs are very low for all
settlements.
Peaks were less clear in PLP for seropositivity to P.
vivax antigens, suggesting that P. vivax transmission may
not have undergone a distinct reduction. A PvSE antigen
was not available at the time of processing; it is possible
that evidence for a change in transmission would have
been detected with this antigen, as was seen with the P.
falciparum equivalent.
On Aneityum, it appeared that changes in age seroprev-
a l e n c e  w e r e  m o r e  r e a d i l y  d e t e c t e d  i n  p o p u l a t i o n  P f S E
antibodies. The PfSE log likelihood indicated a change
occurred approximately 23 years ago (18-38 years); the
PfMSP-119 PLP indicated a change occurred between 25
and 31 years ago, although this was not significant (Figure
7). The PvAMA seroprevalence curve for Aneityum (Fig-
ure 7) showed some evidence for a change in force of
infection, although this was not reflected in the fitted
model.
Evidence for elimination?
The current SCRs for all antigens for both species were
very low in Aneityum. Only the PfSE seroprevalence
curve showed evidence of a clear change-point (Figure 6).
However, in areas where malaria is thought to be elimi-
nated, it is pertinent to investigate individual positive
responses. Seroprevalence to specific malarial antigens in
Aneityum was 10% (54/516) and 13% (65/505) for P. falci-
parum and P. vivax specific antigens respectively. Sero-
positive status was mainly restricted to older individuals.
However, six children under 7 were seropositive for one
Figure 4 The distribution of seroprevalence in children aged 1-10 (inclusive) in settlements on Tanna. Seroprevalence to specific P. falciparum 
antigens (MSP-119 and/or AMA-1) in children aged 1-10 (inclusive) is plotted in figure 4a and the equivalent for P.vivax in Figure 4b. Young children 
were chosen to represent local transmission as they are less likely to have travelled to areas of higher transmission. In some cases, under 10 children 
were sampled from a single village- these are represented by smaller circular symbols, whilst the larger symbols represent villages where more than 
ten, and up to 48 children were sampled.Cook et al. Malaria Journal 2010, 9:169
http://www.malariajournal.com/content/9/1/169
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or both P. falciparum antigens and five children under 7
were seropositive to one or both P. vivax antigens. Two of
the children positive for P. falciparum antigens were
reported to be one years old and antibodies may have
been of maternal origin. Two children, aged 2 and aged 6,
were positive to all antigens tested for both species.
The Northern settlement of Port Patrick on Aneityum
had a higher proportion of seropositive individuals.
Twenty-nine percent (20/70) of the individuals tested
from Port Patrick were seropositive to P. falciparum spe-
cific antigens and 25% (17/68) were seropositive to P.
vivax antigens, compared to 8% (34/446) and 11% (48/
437) in Anel. When controlled for age group, people in
Port Patrick were 5 times more likely to be P. falciparum
seropositive and twice as likely to be P. vivax seropositive.
Thirty-three percent (4/12) of the under 7 s (born since
the 2002 epidemic) in Port Patrick were positive for P. fal-
ciparum antigens compared to 2% (2/91) of under 7 s in
Figure 5 Profile likelihood plots (PLPs) for PfMSP-119 and PfSE for a) Northern Tanna b) Northern Tanna Highlands c) Southern Tanna and 
d) Aneityum. Profile likelihood plots (PLPs) show the log likelihood of a catalytic conversion model allowing for a change in transmission occurring 
at iterative years. The maximum log likelihood is the time point at which a change in transmission is most likely to have occurred. Plots for PfAMA and 
the two P. vivax antigens showed no discernible peaks. The plots for Northern Tanna and Aneityum suggest a change in transmission occurred ap-
proximately 30 years ago, whilst the PLP for Southern Tanna suggests a more recent change between 10 and 20 years ago.
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Anel (p < 0.001), while 20% (2/9) were positive for P. vivax
antigens compared to 3% (3/90) in Anel (p < 0.001). There
was no evidence of clinical infection on the island during
the survey.
Discussion
The Vanuatu government aims to eliminate malaria from
Tafea province (which includes Tanna & Aneityum) in
the next six years. It is thought that malaria has already
been eliminated from Aneityum [3] and that transmission
is confined to specific locations across Tanna. In this
study, the applicability of using serological methods to
provide current estimates of transmission intensity was
assessed and the utility of serology to provide evidence
for the cessation of transmission in Aneityum was also
investigated.
Seroepidemiological studies are especially useful in low
transmission settings where the sensitivity of parasite
prevalence surveys is limited by the scarcity of parasite
positive individuals. This study was undertaken in the dry
season, and as such only three RDT positives (0.2% of the
population surveyed) were found in the population. In
the previous wet season, surveys using PCR methods in
the same areas on Tanna found 1% prevalence of P. falci-
parum and 2.2% prevalence of P. vivax infection in chil-
dren between 2-11 years old [22]. Both parasite-based
prevalence measures, which offer a snapshot of malaria
prevalence and are influenced by temporal changes, are,
not surprisingly, significantly lower than the antibody
prevalence data (which offers a period prevalence mea-
sure) for Tanna in this study (24%, 299/1242 P. falciparum
Figure 6 Seroprevalence curves for all P. falciparum antigens for each settlement. Seroprevalence curves represent the rate at which a commu-
nity becomes seropositive to specific antigens, resulting in a seroconversion rate (SCR) or lambda (λ). A model allowing for a change in transmission 
intensity at a point in time has been fitted if profile likelihood plots showed a clear peak in log likelihood and if likelihood ratio tests resulted in a p < 
0.05. In each graph points represent age seroprevalence (divided into deciles), unbroken lines represent maximum likelihood curves and broken lines 
95% confidence intervals. Resulting lambdas (λ) and 95% confidence intervals are shown on seroprevalence curves. The Aneiytum PfAMA seropreva-
lence is uniformly low across all ages resulting in no seroconversion rate estimate.
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and 20%, 253/1242 P. vivax). This extra sensitivity allows
for a more detailed examination of malaria transmission.
Modelling changes in transmission intensity can give an
insight into the success of interventions in a particular
area. Perhaps surprisingly, changes in transmission were
most readily detected using PfSE. Schizont extract con-
tains multiple proteins some of which will be antigenic
and similar between parasite species, it is, therefore, not
surprising that PfSE has the highest overall seropreva-
lence. However, whilst adults demonstrate high seroprev-
alence to PfSE, seroprevalence in children is lower than
for the more specific antigens, MSP-119 and AMA-1. It is
Figure 7 Seroprevalence curves for all P. vivax antigens for each settlement. In each graph points represent age seroprevalence by decile. Un-
broken lines represent maximum likelihood curves and broken lines 95% confidence intervals. Where possible, resulting lambdas (λ) and 95% confi-
dence intervals are shown on seroprevalence curves.
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not clear why this should be; it may be the result of lower
exposure in children resulting in lower levels of antibod-
ies to the antigens in PfSE. This has been demonstrated in
Kenya, where individuals were more likely to have anti-
b o d i e s  t o  s p e c i f i c  a n t i g e n s  r a t h e r  t h a n  P f S E  [ 3 0 ] .  A n
alternative explanation is that the relative concentration
of the specific antigens is lower in PfSE- this needs fur-
ther investigation.
Statistical analysis of the seroprevalence profiles sug-
gests that a significant drop in transmission occurred
approximately 30 years ago. These seroprevalence curves
are consistent with those described by Kaneko et al (sub-
mitted) using a P. falciparum lysate. However, analysis of
country-wide case data suggests that a drop in malaria
cases occurred in 1992 (17 years before this study), which
was attributed to ITN distribution across the islands [24].
There are two (not mutually exclusive) potential explana-
tions for this. Firstly, the drop in seroprevalence may indi-
cate that the IRS campaign in place in the early 1980s
successfully reduced exposure. At the time, this campaign
was considered unsuccessful due to little reduction
exhibited in national parasite rates. However, it is possi-
ble that it was effective in certain areas such as Northern
Tanna and on Aneityum. An alternative explanation is
that the reduction in seroprevalence is related to the later
malaria control programme that was implemented
nationwide in 1988 and in Aneityum in 1991, and which
resulted in the elimination of malaria from Aneityum [3].
The observation that the step in serological data occurs
approximately 10 years before this point in this scenario
is possibly due to differential rates of loss of antibodies
with age. Younger children who had low antibody levels
when the 1988 interventions were implemented, may
have lost these antibodies more rapidly than older indi-
viduals with a more established antibody response
[31,32]. Clearly more information on the rates of anti-
body loss is required to allow a full interpretation of these
data, and further work is ongoing.
The observation that immune responses to the specific
antigens do not reflect the changes in transmission is per-
plexing. Transmission is known to be very low across
Tanna and it is possible that in these conditions models
for assessing for an increase in seropositivity with age
may be inappropriate. Several of the age stratified curves
demonstrate little to no increase in seroprevalence with
age. In areas where transmission has been consistently
low for many years a loss in seropositivity in older indi-
viduals may result in uniform seropositivity across the
population; masking any change-point in transmission.
This is clearly not the case for the multi-antigenic PfSE-
one might expect an increased chance that antibodies to
this conglomeration of antigens have longer half lives,
although this was not observed in a longitudinal study in
Thailand [33]. In a situation where age seroprevalence
reveals little information, it may be more pertinent to
investigate antibody titres and to focus on children born
since interventions have been in place. This work is ongo-
ing.
It is important to understand the dynamics in the trans-
mission of different species in areas where more than one
species of Plasmodium are transmitted. Serological mea-
sures have allowed us to successfully distinguish between
areas where P. falciparum and P. vivax malaria are trans-
mitted. Current SCRs are low for both species but consis-
tently higher for P. vivax in all areas. Seropositivity to P.
vivax antigens was much higher in younger individuals,
suggesting either that transmission of this species has
been higher than P. falciparum transmission over the past
10 years, or that preferential infection of younger age
groups, as has been reported previously [34], results in a
different age seroprevalence curve than is found with P.
falciparum seroprevalence. Additionally, morbidity data
from previous studies in Vanuatu [35] and Papua New
Guinea [36] show that clinical immunity to P. vivax builds
up faster than for P. falciparum which could explain the
seemingly high seroprevalence in younger children. The
high proportion of P. vivax seropositive individuals in
younger age groups in Northern Tanna made the data dif-
ficult to fit the conventional seroconversion model. A
similar age seroprevalence profile would be expected in
areas where there has been an epidemic as the result of a
defined period of exposure in all ages of the population.
However, the effect of possible presence of hypnozoites in
P. vivax infections has not previously been studied and we
do not know how infections that are the result of hypno-
zoites (i.e. relapses) influence serological profiles. Previ-
ous data has shown that P. falciparum is more
successfully reduced by interventions than P. vivax, due
to the limited effects interventions have on relapses, and
due to differences in biting behaviour by mosquitoes
infected with each species [37]. The profile likelihood
plots do not indicate a clear change in transmission inten-
sity based on seroprevalence of P. vivax antibodies. The
drop in P. vivax transmission may not have been as pro-
nounced or sudden as the P. falciparum reduction, in
which case, a step in the seroprevalence curves would not
be evident. P. vivax prevalence tends to be higher in areas
of low transmission intensity [38], and an increase in P.
vivax  cases has been reported in areas where P. falci-
parum transmission appears to be on the decline [39,40].
H o w e v e r ,  o n  A n e i t y u m  c l e a r  e v i d e n c e  o f  a  c h a n g e  i n
transmission for P. vivax was seen in seroprevalence data
by Kaneko et al (submitted); this data also indicated a
change in transmission had occurred in the early 1980s.
This study used a lysed P.vivax  preparation as antigen
which, as for the P. falciparum equivalent, may be more
likely to detect changes in a polymorphic antibody
response.Cook et al. Malaria Journal 2010, 9:169
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The P. vivax epidemic in 2002 may also have had an
adverse effect on the seroprevalence curves to P. vivax
antigens in Aneityum. There have been no reported cases
since 2002, and whilst seropositivity on this island is
mainly restricted to adults, low seropositivity in children
under 7 suggests that there may still be residual transmis-
sion in the area. However, importantly, four of the 11 chil-
dren seropositive to any antigen (falciparum or vivax)
were classified as aged one. Birthdays and ages are not
generally recorded in Aneityum, and it is possible these
children were younger than one and, therefore, the anti-
bodies detected could represent residual maternal anti-
bodies. Alternatively, children may have been exposed to
malaria whilst away from the island. Limited information
was collected on travel history during the survey so this
possible explanation cannot be confirmed. Monitoring of
cases on Aneityum is very thorough, with everyone
returning to the island tested for infection via thick and
thin slide films. However, slide reading has limited sensi-
tivity, and it is possible that some people may have
arrived carrying infection. PCR methods detect parasites
more sensitively and it may be pertinent to check for sub-
patent infections amongst the inhabitants of Aneityum.
Imported malaria can remain a problem as long as
Anopheline mosquitoes are present on the island. This
highlights the importance of continued monitoring and
surveillance on islands where elimination has been
achieved [41], and the recording of accurate travel history
information.
An alternative explanation for the observed seroposi-
tivity in young children is the presence of antibodies
cross-reacting with antigens from other infectious agents
[42-44]. Detecting antibodies to specific recombinant
antigens using ELISA, rather than the less specific immu-
nofluoresence antibody test (IFAT) minimizes this dan-
ger. However, a few studies have suggested the cross-
reactive potential of PfAMA with Toxoplasma antigens
[45,46], although this infection is reportedly not preva-
lent in Vanuatu.
Conclusion
Malaria transmission is notably heterogeneous, and this
will become more pronounced as transmission decreases.
For malaria elimination, areas where residual transmis-
sion is occurring need to be identified in order to target
interventions to communities where they are most
needed. In Vanuatu, interventions have been very suc-
cessful at reducing MTI over the past 20 years. However,
areas of higher transmission were identified on Tanna
during the 2008 survey [22]. Serological analysis and
monitoring of these areas can offer further insight into
the dynamics of malaria transmission. The additional
sensitivity afforded by the longevity of antibody
responses also allows an examination of the success of
control measures also in confirming the cessation of
transmission. Serological measures are robust and high
throughput and importantly, remain sensitive in very low
transmission settings.
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